866-997-4948(US-Canada Toll Free)

United States Paclitaxel-eluting Stent Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Stent

No. of Pages : 105 Pages

In this report, the United States Paclitaxel-eluting Stent market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Paclitaxel-eluting Stent in these regions, from 2012 to 2022 (forecast).

United States Paclitaxel-eluting Stent market competition by top manufacturers/players, with Paclitaxel-eluting Stent sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
Terumo Medical
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sorin

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Metal Stent
Polymer Stent
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Paclitaxel-eluting Stent for each application, including
Coronary Heart Disease
Clinical
Others

Table of Contents

United States Paclitaxel-eluting Stent Market Report 2017
1 Paclitaxel-eluting Stent Overview
1.1 Product Overview and Scope of Paclitaxel-eluting Stent
1.2 Classification of Paclitaxel-eluting Stent by Product Category
1.2.1 United States Paclitaxel-eluting Stent Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Paclitaxel-eluting Stent Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Metal Stent
1.2.4 Polymer Stent
1.2.5 Others
1.3 United States Paclitaxel-eluting Stent Market by Application/End Users
1.3.1 United States Paclitaxel-eluting Stent Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.3.4 Others
1.4 United States Paclitaxel-eluting Stent Market by Region
1.4.1 United States Paclitaxel-eluting Stent Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Paclitaxel-eluting Stent Status and Prospect (2012-2022)
1.4.3 Southwest Paclitaxel-eluting Stent Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Paclitaxel-eluting Stent Status and Prospect (2012-2022)
1.4.5 New England Paclitaxel-eluting Stent Status and Prospect (2012-2022)
1.4.6 The South Paclitaxel-eluting Stent Status and Prospect (2012-2022)
1.4.7 The Midwest Paclitaxel-eluting Stent Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Paclitaxel-eluting Stent (2012-2022)
1.5.1 United States Paclitaxel-eluting Stent Sales and Growth Rate (2012-2022)
1.5.2 United States Paclitaxel-eluting Stent Revenue and Growth Rate (2012-2022)

2 United States Paclitaxel-eluting Stent Market Competition by Players/Suppliers
2.1 United States Paclitaxel-eluting Stent Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Paclitaxel-eluting Stent Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Paclitaxel-eluting Stent Average Price by Players/Suppliers (2012-2017)
2.4 United States Paclitaxel-eluting Stent Market Competitive Situation and Trends
2.4.1 United States Paclitaxel-eluting Stent Market Concentration Rate
2.4.2 United States Paclitaxel-eluting Stent Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Paclitaxel-eluting Stent Manufacturing Base Distribution, Sales Area, Product Type

3 United States Paclitaxel-eluting Stent Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Paclitaxel-eluting Stent Sales and Market Share by Region (2012-2017)
3.2 United States Paclitaxel-eluting Stent Revenue and Market Share by Region (2012-2017)
3.3 United States Paclitaxel-eluting Stent Price by Region (2012-2017)

4 United States Paclitaxel-eluting Stent Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Paclitaxel-eluting Stent Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Paclitaxel-eluting Stent Revenue and Market Share by Type (2012-2017)
4.3 United States Paclitaxel-eluting Stent Price by Type (2012-2017)
4.4 United States Paclitaxel-eluting Stent Sales Growth Rate by Type (2012-2017)

5 United States Paclitaxel-eluting Stent Sales (Volume) by Application (2012-2017)
5.1 United States Paclitaxel-eluting Stent Sales and Market Share by Application (2012-2017)
5.2 United States Paclitaxel-eluting Stent Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Paclitaxel-eluting Stent Players/Suppliers Profiles and Sales Data
6.1 Abbott Vascular
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbott Vascular Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Advantec Vascular
6.2.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Advantec Vascular Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 B.Braun Melsengen AG
6.3.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 B.Braun Melsengen AG Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Biosensors
6.4.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Biosensors Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Biotronik
6.5.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biotronik Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Blue Medical
6.6.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Blue Medical Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Boston Scientific
6.7.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Boston Scientific Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 DISA Vascular
6.8.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 DISA Vascular Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Essen
6.9.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Essen Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Medtronic Vascular
6.10.2 Paclitaxel-eluting Stent Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Medtronic Vascular Paclitaxel-eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 MicroPort Medical
6.12 Terumo Medical
6.13 Orbusneich
6.14 Promed Medical
6.15 Relisys Medical
6.16 Reva Medical
6.17 Sahajanand
6.18 Sorin

7 Paclitaxel-eluting Stent Manufacturing Cost Analysis
7.1 Paclitaxel-eluting Stent Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Paclitaxel-eluting Stent

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Paclitaxel-eluting Stent Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Paclitaxel-eluting Stent Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Paclitaxel-eluting Stent Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Paclitaxel-eluting Stent Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Paclitaxel-eluting Stent Sales Volume Forecast by Type (2017-2022)
11.3 United States Paclitaxel-eluting Stent Sales Volume Forecast by Application (2017-2022)
11.4 United States Paclitaxel-eluting Stent Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Paclitaxel-eluting Stent
Figure United States Paclitaxel-eluting Stent Market Size (K Units) by Type (2012-2022)
Figure United States Paclitaxel-eluting Stent Sales Volume Market Share by Type (Product Category) in 2016
Figure Metal Stent Product Picture
Figure Polymer Stent Product Picture
Figure Others Product Picture
Figure United States Paclitaxel-eluting Stent Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Paclitaxel-eluting Stent by Application in 2016
Figure Coronary Heart Disease Examples
Figure Clinical Examples
Figure Others Examples
Figure United States Paclitaxel-eluting Stent Market Size (Million USD) by Region (2012-2022)
Figure The West Paclitaxel-eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Paclitaxel-eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Paclitaxel-eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Paclitaxel-eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Paclitaxel-eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Paclitaxel-eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Paclitaxel-eluting Stent Sales (K Units) and Growth Rate (2012-2022)
Figure United States Paclitaxel-eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Paclitaxel-eluting Stent Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Paclitaxel-eluting Stent Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Paclitaxel-eluting Stent Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Paclitaxel-eluting Stent Sales Share by Players/Suppliers
Figure 2017 United States Paclitaxel-eluting Stent Sales Share by Players/Suppliers
Figure United States Paclitaxel-eluting Stent Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Paclitaxel-eluting Stent Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Paclitaxel-eluting Stent Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Paclitaxel-eluting Stent Revenue Share by Players/Suppliers
Figure 2017 United States Paclitaxel-eluting Stent Revenue Share by Players/Suppliers
Table United States Market Paclitaxel-eluting Stent Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Paclitaxel-eluting Stent Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Paclitaxel-eluting Stent Market Share of Top 3 Players/Suppliers
Figure United States Paclitaxel-eluting Stent Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Paclitaxel-eluting Stent Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Paclitaxel-eluting Stent Product Category
Table United States Paclitaxel-eluting Stent Sales (K Units) by Region (2012-2017)
Table United States Paclitaxel-eluting Stent Sales Share by Region (2012-2017)
Figure United States Paclitaxel-eluting Stent Sales Share by Region (2012-2017)
Figure United States Paclitaxel-eluting Stent Sales Market Share by Region in 2016
Table United States Paclitaxel-eluting Stent Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Paclitaxel-eluting Stent Revenue Share by Region (2012-2017)
Figure United States Paclitaxel-eluting Stent Revenue Market Share by Region (2012-2017)
Figure United States Paclitaxel-eluting Stent Revenue Market Share by Region in 2016
Table United States Paclitaxel-eluting Stent Price (USD/Unit) by Region (2012-2017)
Table United States Paclitaxel-eluting Stent Sales (K Units) by Type (2012-2017)
Table United States Paclitaxel-eluting Stent Sales Share by Type (2012-2017)
Figure United States Paclitaxel-eluting Stent Sales Share by Type (2012-2017)
Figure United States Paclitaxel-eluting Stent Sales Market Share by Type in 2016
Table United States Paclitaxel-eluting Stent Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Paclitaxel-eluting Stent Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Paclitaxel-eluting Stent by Type (2012-2017)
Figure Revenue Market Share of Paclitaxel-eluting Stent by Type in 2016
Table United States Paclitaxel-eluting Stent Price (USD/Unit) by Types (2012-2017)
Figure United States Paclitaxel-eluting Stent Sales Growth Rate by Type (2012-2017)
Table United States Paclitaxel-eluting Stent Sales (K Units) by Application (2012-2017)
Table United States Paclitaxel-eluting Stent Sales Market Share by Application (2012-2017)
Figure United States Paclitaxel-eluting Stent Sales Market Share by Application (2012-2017)
Figure United States Paclitaxel-eluting Stent Sales Market Share by Application in 2016
Table United States Paclitaxel-eluting Stent Sales Growth Rate by Application (2012-2017)
Figure United States Paclitaxel-eluting Stent Sales Growth Rate by Application (2012-2017)
Table Abbott Vascular Basic Information List
Table Abbott Vascular Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Vascular Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure Abbott Vascular Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure Abbott Vascular Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table Advantec Vascular Basic Information List
Table Advantec Vascular Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Advantec Vascular Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure Advantec Vascular Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure Advantec Vascular Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table B.Braun Melsengen AG Basic Information List
Table B.Braun Melsengen AG Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure B.Braun Melsengen AG Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure B.Braun Melsengen AG Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure B.Braun Melsengen AG Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table Biosensors Basic Information List
Table Biosensors Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosensors Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure Biosensors Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure Biosensors Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table Biotronik Basic Information List
Table Biotronik Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biotronik Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure Biotronik Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure Biotronik Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table Blue Medical Basic Information List
Table Blue Medical Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Blue Medical Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure Blue Medical Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure Blue Medical Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table Boston Scientific Basic Information List
Table Boston Scientific Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure Boston Scientific Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure Boston Scientific Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table DISA Vascular Basic Information List
Table DISA Vascular Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DISA Vascular Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure DISA Vascular Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure DISA Vascular Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table Essen Basic Information List
Table Essen Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Essen Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure Essen Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure Essen Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table Medtronic Vascular Basic Information List
Table Medtronic Vascular Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic Vascular Paclitaxel-eluting Stent Sales Growth Rate (2012-2017)
Figure Medtronic Vascular Paclitaxel-eluting Stent Sales Market Share in United States (2012-2017)
Figure Medtronic Vascular Paclitaxel-eluting Stent Revenue Market Share in United States (2012-2017)
Table MicroPort Medical Basic Information List
Table Terumo Medical Basic Information List
Table Orbusneich Basic Information List
Table Promed Medical Basic Information List
Table Relisys Medical Basic Information List
Table Reva Medical Basic Information List
Table Sahajanand Basic Information List
Table Sorin Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Paclitaxel-eluting Stent
Figure Manufacturing Process Analysis of Paclitaxel-eluting Stent
Figure Paclitaxel-eluting Stent Industrial Chain Analysis
Table Raw Materials Sources of Paclitaxel-eluting Stent Major Players/Suppliers in 2016
Table Major Buyers of Paclitaxel-eluting Stent
Table Distributors/Traders List
Figure United States Paclitaxel-eluting Stent Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Paclitaxel-eluting Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Paclitaxel-eluting Stent Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Paclitaxel-eluting Stent Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Paclitaxel-eluting Stent Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Paclitaxel-eluting Stent Sales Volume (K Units) Forecast by Type in 2022
Table United States Paclitaxel-eluting Stent Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Paclitaxel-eluting Stent Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Paclitaxel-eluting Stent Sales Volume (K Units) Forecast by Application in 2022
Table United States Paclitaxel-eluting Stent Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Paclitaxel-eluting Stent Sales Volume Share Forecast by Region (2017-2022)
Figure United States Paclitaxel-eluting Stent Sales Volume Share Forecast by Region (2017-2022)
Figure United States Paclitaxel-eluting Stent Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *